Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F7 | P08709 | 1/20 | 0.35 |
| ▸ | F3 | P13726 | 1/20 | 0.35 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 3/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.35 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.32 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3486091 | 0.78 | SRC (0.39) | MAPTKDM4ENPC1RAB9AUSP2 | |
| Phosphoric Acid SCHEMBL3486158 | 0.77 | KDM4E (0.41) | F7F3DYRK1AMAPTKDM4E | |
| SCHEMBL10912104 | 0.70 | KDM4E (0.47) | F7F3DYRK1AMAPTKDM4E | |
| SCHEMBL3485169 | 0.70 | KMT2A (0.47) | NPC1RAB9AMEN1ALDH1A1KMT2A | |
| SCHEMBL25232020 | 0.68 | F7 (0.46) | F7F3DYRK1AMAPTKDM4E | |
| SCHEMBL12126371 | 0.66 | F7 (0.45) | F7F3DYRK1AMAPTKDM4E | |
| SCHEMBL29018345 | 0.66 | KCNMA1 (0.48) | MAPTKDM4ENPC1RAB9ACA1 | |
| SCHEMBL27522759 | 0.65 | F7 (0.43) | F7F3DYRK1AMAPTKDM4E | |
| SCHEMBL205114 | 0.63 | CNR1 (0.39) | DYRK1AMAPTKDM4ENPC1RAB9A | |
| SCHEMBL27627295 | 0.63 | MAPT (0.53) | MAPTKDM4ENPC1RAB9AATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100029008-A1 | POLYMERASE-INDEPENDENT ANALYSIS OF THE SEQUENCE OF POLYNUCLEOTIDES | FEBIT BIOTECH GMBH (DE) | 2010-02-04 | — | — | US | claimed |
| EP-1828217-A2 | POLYMERASE-INDEPENDENT ANALYSIS OF THE SEQUENCE OF POLYNUCLEOTIDES | Febit Biotech GmbH (DE) | 2007-09-05 | — | — | EP | claimed |
| WO-2006063717-A2 | POLYMERASE-INDEPENDENT ANALYSIS OF THE SEQUENCE OF POLYNUCLEOTIDES | FEBIT BIOTECH GMBH (DE) | 2006-06-22 | — | — | WO | claimed |
| US-20100029008-A1 | POLYMERASE-INDEPENDENT ANALYSIS OF THE SEQUENCE OF POLYNUCLEOTIDES | FEBIT BIOTECH GMBH (DE) | 2010-02-04 | — | — | US | disclosed |
| EP-1828217-A2 | POLYMERASE-INDEPENDENT ANALYSIS OF THE SEQUENCE OF POLYNUCLEOTIDES | Febit Biotech GmbH (DE) | 2007-09-05 | — | — | EP | disclosed |
| WO-2006063717-A2 | POLYMERASE-INDEPENDENT ANALYSIS OF THE SEQUENCE OF POLYNUCLEOTIDES | FEBIT BIOTECH GMBH (DE) | 2006-06-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100029008-A1 | POLYMERASE-INDEPENDENT ANALYSIS OF THE SEQUENCE OF POLYNUCLEOTIDES | POLB, POLM, POLN | F7 3975/4885F3 3346/4885DYRK1A 3196/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.